These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7692356)

  • 21. Persistence of antibodies to hepatitis C virus in a chronic hemodialysis population.
    Carrera F; Silva JG; Oliveira C; Frazao JM; Pires C
    Nephron; 1994; 68(1):38-40. PubMed ID: 7527504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of hepatitis C virus antibodies in hemodialysis patients and dialysis staff.
    Fujiyama S; Kawano S; Sato S; Tanaka M; Goto M; Taura Y; Sato T; Kawahara T; Mizuno K
    Hepatogastroenterology; 1992 Apr; 39(2):161-5. PubMed ID: 1378811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C virus in hemodialysis patients.
    Dentico P; Volpe A; Buongiorno R; Carlone A; Carbone M; Manno M
    Nephron; 1992; 61(3):307-8. PubMed ID: 1323776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C virus antibody positive blood donors.
    Mutimer D; Shaw J; Harrison R; Ala F; Neuberger J; Elias E
    Gut; 1993; 34(2 Suppl):S54. PubMed ID: 7686116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and significance of antibodies to hepatitis C virus among Saudi haemodialysis patients.
    Ayoola EA; Huraib S; Arif M; al-Faleh FZ; al-Rashed R; Ramia S; al-Mofleh IA; Abu-Aisha H
    J Med Virol; 1991 Nov; 35(3):155-9. PubMed ID: 1725179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
    Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
    Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Late seroconversion of C virus markers in hemodialysis patients.
    Oliva JA; Maymo RM; Carrio J; Delgado O; Mallafre JM
    Kidney Int Suppl; 1993 Jun; 41():S153-6. PubMed ID: 7686592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of the patients with low levels of anti-HCV positivity].
    Zer Y; Karaoğlan I; Ciçek H; Karağoz ID; Sağlam M
    Mikrobiyol Bul; 2009 Jan; 43(1):133-9. PubMed ID: 19334390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of antibodies to hepatitis C in dialysis patients and transplant recipients with possible routes of transmission.
    Conway M; Catterall AP; Brown EA; Tibbs C; Gower PE; Curtis JR; Coleman JC; Murray-Lyon IM
    Nephrol Dial Transplant; 1992; 7(12):1226-9. PubMed ID: 1283447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occult hepatitis C virus infection among haemodialysis patients.
    Ali NK; Mohamed RR; Saleh BE; Alkady MM; Farag ES
    Arab J Gastroenterol; 2018 Sep; 19(3):101-105. PubMed ID: 30245116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of hepatitis C infection in a hemodialysis unit.
    Colombo P; Filiberti O; Porcu M; Costantini L; Mangione A; Monzeglio C; Peona C
    Nephron; 1992; 61(3):326-7. PubMed ID: 1323782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-hepatitis C virus antibodies and hepatitis C virus viraemia in haemodialysis patients.
    Picciotto A; Varagona G; Gurreri G; Fiorini F; Sofia A; Coviello DA; Bonanni P; Icardi GC; Valle F; Celle G
    Nephrol Dial Transplant; 1993; 8(10):1115-7. PubMed ID: 8272226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Virological features of hepatitis C virus infection in hemodialysis patients.
    Silini E; Bono F; Cerino A; Piazza V; Solcia E; Mondelli MU
    J Clin Microbiol; 1993 Nov; 31(11):2913-7. PubMed ID: 7505292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody responses to hepatitis C virus and its modes of transmission in dialysis patients.
    Almroth G; Ekermo B; Franzén L; Hed J
    Nephron; 1991; 59(2):232-5. PubMed ID: 1659671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of antibody to hepatitis C virus in hemodialysis patients.
    Hayashi J; Nakashima K; Kajiyama W; Noguchi A; Morofuji M; Maeda Y; Kashiwagi S
    Am J Epidemiol; 1991 Sep; 134(6):651-7. PubMed ID: 1659184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C infection in potential recipients with normal liver biochemistry does not preclude renal transplantation.
    Kazi S; Prasad S; Pollak R; Holzer T; Heynen C; Fabrega AJ; Pitrak D; Layden TJ
    Dig Dis Sci; 1994 May; 39(5):961-4. PubMed ID: 7513631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Infection of hepatitis C virus in patients with chronic renal failure undergoing hemodialysis therapy and staff members].
    Miyasaka M
    Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):989-99. PubMed ID: 1722830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis-C virus antibodies (anti HCV) in haemodialyzed vs non-dialyzed patients.
    Kumar H; Naqvi SA; Ahmed A; Hamid S
    J Pak Med Assoc; 1994 Feb; 44(2):28-30. PubMed ID: 8040988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibodies against non-structural c100/3 and structural core antigen of hepatitis C virus (HCV) in hemodialysis patients.
    Yoshida CF; Takahashi Y; Vanderborght BO; Rouzere CD; França MS; Takahashi C; Takamizawa A; Yoshida I; Schatzmayr HG
    Rev Inst Med Trop Sao Paulo; 1993; 35(4):315-21. PubMed ID: 7509506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and risk factors of hepatitis C virus infection in a haemodialysis unit.
    Forns X; Fernández-Llama P; Pons M; Costa J; Ampurdanés S; López-Labrador FX; Olmedo E; López-Pedret J; Darnell A; Revert L; Sánchez-Tapias JM; Rodés J
    Nephrol Dial Transplant; 1997 Apr; 12(4):736-40. PubMed ID: 9141004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.